MRI scan breakthrough could spare thousands of heart patients from risky invasive tests

Doctors may soon be able to tell just how sick a heart failure patient really is by using a routine MRI scan, thanks to new research from the University of East Anglia.

People with heart failure often need a test called right heart catheterisation, where a tube is inserted into the heart to measure oxygen levels in the blood. This helps doctors understand how severe the condition is.

But the invasive procedure is far from pleasant and carries risks, especially for older, frail or unwell patients.

In collaboration with researchers at the University of Leeds and Newcastle University, the team developed a way to estimate this crucial measurement of blood oxygen using a standard cardiac MRI.

Now, they hope their findings could potentially spare thousands from undergoing the risky tube procedure in future.

A potential game changer

Lead researcher Prof Pankaj Garg, from UEA’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, said: “Heart failure affects hundreds of thousands of people in the UK and significantly weakens the heart’s ability to pump blood. Doctors often need detailed information about a patient’s circulation to decide on the best treatment.

“We wanted to develop a safe, non-invasive alternative which could allow far more patients to be properly assessed - and allow repeat monitoring without the risks of a catheter test.

“Our breakthrough could be a game changer for assessing advanced heart failure. It could allow us to measure risk more safely and more often, especially for patients who are too frail or high-risk for an invasive catheter procedure.”

How the research happened

The team developed a method that uses a routine type of MRI measurement called T2 mapping to estimate how much oxygen is left in the blood as it returns to the heart - a key marker of how well the heart is coping.

Prof Garg said: “Blood with different oxygen levels behaves slightly differently in a magnetic field. By measuring how that blood reacts, we were able to develop a formula that predicts the oxygen reading without ever inserting a tube or taking a blood sample.”

The researchers first tested the technique in 30 patients and found the MRI results closely matched the invasive catheter readings.

They then analysed 628 people with newly diagnosed heart failure, following them for around three years. Those with healthier oxygen readings on MRI were significantly less likely to die or end up in hospital due to their condition.

Crucially, this MRI-based measure stayed accurate even after accounting for age, other illnesses and overall heart function.

Faster, safer heart checks

Prof Garg said: “One of the most important markers in advanced heart failure is how much oxygen is left in blood returning to the right side of the heart. Until now, getting that number has usually meant a tube test. Our study shows it can be estimated non-invasively from a standard heart MRI.”

Senior author Dr Peter Swoboda, from the University of Leeds, added: “This means we may be able to read off a crucial haemodynamic number from an everyday scan - effectively turning a routine MRI into a much more powerful test, without putting a tube into the heart.”

Co-author Dr Gareth Matthews, from the University of East Anglia, said: “Because this can be done as part of a standard cardiac MRI, it needs no extra hardware and no contrast dye, and adds only seconds to the scan.

“It has real potential to widen access to safer heart failure assessment across the NHS,” he added.

The researchers say further studies are needed to confirm the findings in different hospitals and patient groups, and to understand how best to use the measure in day-to-day decision-making.

‘Development and validation of a non-invasive model of mixed venous oxygen saturation in heart failure’ is published in the journal JACC Advances.

Reference:

Prof Pankaj Garg, Development and validation of a non-invasive model of mixed venous oxygen saturation in heart failure,JACC Advances.